Learn More
IBL America Anti-Adalimumab (Humira) Confirmatory Reagent
Supplier: IBL America TM09009CR
The Confirmatory Reagent contains the drug Infliximab (Remicade) lyophilized. The reconstituted Confirmatory Reagent is designed for use as a competition/inhibition test for the confirmation of samples which have been ADA positive in the initial screening test coded Cat#. Used as a complementary component for Anti-Infliximab (Remicade) (ATI) ELISA.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.